Mangoceuticals, Inc. (NASDAQ:MGRX) Stock Short Interest Report for October

Posted by Andrew Walz on Oct 27th, 2026

Mangoceuticals, Inc. (NASDAQ:MGRX – Get Free Report) saw a large decrease in short interest in October. As of October 15th, there was short interest totaling 91,564 shares, a decrease of 79.1% from the September 30th total of 438,786 shares. Based on an average daily volume of 739,664 shares, the short-interest ratio is currently 0.1 days. Approximately 0.5% of the company’s stock are short sold.

Mangoceuticals Stock Up 5.3%

Shares of Mangoceuticals stock opened at $0.24 on Tuesday. The firm has a market cap of $5.27 million, a P/E ratio of -0.24 and a beta of 1.98. Mangoceuticals has a fifty-two week low of $0.16 and a fifty-two week high of $2.41. The business has a 50-day moving average price of $0.40 and a 200 day moving average price of $0.42.

Mangoceuticals (NASDAQ:MGRX – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.09) earnings per share (EPS) for the quarter. Mangoceuticals had a negative net margin of 4,794.60% and a negative return on equity of 96.39%. The firm had revenue of $0.08 million for the quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MGRX. Wall Street Zen raised shares of Mangoceuticals to a “sell” rating in a research report on Saturday, July 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Mangoceuticals in a report on Monday, September 21st. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has a consensus rating of “Sell”.

Read Our Latest Research Report on Mangoceuticals

Mangoceuticals Company Profile

(Get Free Report)

Mangoceuticals, Inc, doing business as MangoRx, is a men’s health and wellness company that operates a direct-to-consumer telehealth platform. The company provides online access to healthcare consultations, prescription treatments and related products designed to address common men’s health concerns.

Its offerings have included treatments for erectile dysfunction and hair loss, as well as other wellness categories such as testosterone support and weight management. Products are generally marketed through the company’s digital platform and may be provided through prescriptions issued by independent licensed healthcare professionals, where appropriate.

Mangoceuticals serves customers in the United States through its online healthcare model.